AkzoNobel stock holds steady as Axalta merger of equals moves forward

Published on 09/14/2026 at 13:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AkzoNobel stock is trading near the EUR 58 mark on Euronext Amsterdam as of September 13, 2026. The planned all-stock merger of equals with Axalta, with each Axalta share exchanged for 0.6539 AkzoNobel shares, remains on track for closing in late 2026 to early 2027.

Farbenfabrik von Akzo Nobel N.V. an einer Amsterdamer Gracht — Fotorealistische Industrieanlage zeigt Chemiebranche von Akzo Nobel N.V. mit ISIN NL0013267909 an Amsterdamer Gracht, Illustration mit AI erstellt.

AkzoNobel stock (ISIN NL0013267909) is trading around EUR 58 on Euronext Amsterdam as of September 13, 2026, leaving the paint and coatings group near the middle of its recent trading range. The valuation backdrop for investors is increasingly shaped by the planned all-stock merger of equals with Axalta, under which each Axalta share is to be converted into 0.6539 AkzoNobel ordinary shares at closing, as outlined by StockTitan on August 5, 2026.

Merger of equals with Axalta sets strategic tone

According to StockTitan, shareholders of Axalta Coating Systems approved the all-stock merger of equals with AkzoNobel at a special general meeting on August 5, 2026, clearing a key hurdle for the transaction’s completion. The deal structure foresees that each Axalta ordinary share will be converted into 0.6539 AkzoNobel ordinary shares at closing, which means Axalta investors will receive AkzoNobel stock as their consideration and will participate in the combined company’s future performance.

The same filing indicates that completion of the merger remains subject to required regulatory approvals and other customary closing conditions, with closing expected in late 2026 to early 2027, as reported by StockTitan. For AkzoNobel shareholders, this timeline frames when the promised scale benefits, dual headquarters in Amsterdam and Philadelphia and dual listings on the NYSE and Euronext Amsterdam could start to be reflected more fully in reported figures and potentially in the share price.

Axalta fundamentals highlight the merger’s financial dimension

Axalta’s latest reported figures provide a sense of the financial base AkzoNobel is set to combine with. In its Form 10-Q for the second quarter of 2026, Axalta recorded net sales of USD 1,346 million for Q2 2026, representing a 3.1 percent increase year over year, while net income attributable to common shareholders declined to USD 89 million and diluted EPS to USD 0.41 due to higher merger and acquisition-related costs and increased freight and operating charges, according to StockTitan. That comparison underlines how integration costs and input price dynamics already affect the earnings base that will later be consolidated into AkzoNobel’s reporting.

For the first half of 2026, Axalta reported net sales of USD 2,600 million and Segment Adjusted EBITDA of USD 564 million, with lower variable input costs and currency tailwinds helping to offset softer volumes in North America Performance Coatings and less favorable price and mix in Mobility Coatings, again per StockTitan. For investors in AkzoNobel stock, these figures hint at the scale and profitability profile that the merger aims to capture, while also illustrating the exposure to automotive and industrial end markets and the sensitivity to volume trends and pricing.

Risk factors: regulatory approvals and termination fees

The transaction documentation described by StockTitan also highlights reciprocal termination fees of EUR 150 million, which would apply if either party walks away under specified circumstances. For AkzoNobel shareholders, this creates both a financial safeguard that incentivizes deal completion and a potential cost if regulatory or strategic considerations eventually prevent the merger from closing.

In addition, completion remains contingent on approvals from competition and other regulators in multiple jurisdictions, and on customary closing conditions, as noted by StockTitan. This introduces timing and execution risk: any delay beyond late 2026 or early 2027 could prolong the phase in which both companies bear transaction-related costs without yet realizing the full synergy benefits in their reported margins and earnings.

AkzoNobel stock on Euronext Amsterdam

On the market side, AkzoNobel stock is quoted on Euronext Amsterdam under the ticker AKZA. A recent price snapshot from a stock portal shows the shares around EUR 58.08, with a daily move of minus 2.71 percent as of a late session on Euronext Amsterdam, illustrating that the stock can see noticeable day-to-day swings even when there is no new fundamental data released. The same snapshot places the price within a moderate distance of its recent 52-week range, suggesting that the merger story rather than a sharp technical breakout currently anchors investor attention.

For retail investors, the key numbers to watch in the coming months will be AkzoNobel’s next set of quarterly results up to early 2027, the regulatory milestones for the Axalta merger and any updated guidance that quantifies expected synergies in revenue, margins and cash flow. Until those data points arrive, AkzoNobel stock is likely to continue to trade as a classic coatings and specialty chemicals name with an added merger option value, rather than as a pure event-driven situation.